Literature DB >> 15631644

Craniopharyngioma therapy: long-term effects on hypothalamic function.

Nicole J Ullrich1, R Michael Scott, Scott L Pomeroy.   

Abstract

BACKGROUND: Craniopharyngiomas are the most common intracranial tumor of extraneural origin in childhood. REVIEW
SUMMARY: In this review, we discuss the presentation, diagnosis, and treatment of craniopharyngioma. As the survival prognosis of patients with craniopharyngioma is quite optimistic, long-term side effects of both the tumor and its treatment are now better appreciated. Aside from well-recognized hormonal deficiencies and visual deficits related to tumor location, patients are now acknowledged to experience pathologic obesity and deficits of higher cortical function, memory, and behavior. The combination of these deficits can have profoundly detrimental effects on quality of life.
CONCLUSIONS: Careful attention to issues related to hormonal balance, visual field defects, cognitive function, and mood disorders is essential to optimize long-term outcome of patients with craniopharyngioma.

Entities:  

Mesh:

Year:  2005        PMID: 15631644     DOI: 10.1097/01.nrl.0000149971.27684.d4

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  3 in total

1.  Health status in long-term survivors of pediatric craniopharyngiomas.

Authors:  Deborah B Crom; Daniel Smith; Zang Xiong; Arzu Onar; Melissa M Hudson; Thomas E Merchant; E Brannon Morris
Journal:  J Neurosci Nurs       Date:  2010-12       Impact factor: 1.230

2.  Factors influencing quality of life in patients with benign primary brain tumors: prior to and following surgery.

Authors:  Shiow-Luan Tsay; Jui-Yen Chang; Patsy Yates; Kuan-Chia Lin; Shu-Yuan Liang
Journal:  Support Care Cancer       Date:  2010-11-24       Impact factor: 3.603

3.  Decrease in scale invariance of activity fluctuations with aging and in patients with suprasellar tumors.

Authors:  S D Joustra; C Gu; J H T Rohling; L Pickering; M Klose; K Hu; F A Scheer; U Feldt-Rasmussen; P J Jennum; A M Pereira; N R Biermasz; J H Meijer
Journal:  Chronobiol Int       Date:  2017-11-28       Impact factor: 2.877

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.